Wendy K. Kohlmann
No Rating Available
(Learn About Our Rating System)

Wendy K. Kohlmann, MS

Languages spoken: English

Wendy Kohlmann is a board certified genetic counselor with a master's degree from the University of Cincinnati. She joined the University of Utah Huntsman Cancer Institute in 2006. She is the Director of the Genetic Counseling Shared Resource, a core resource supported by the Huntsman Cancer Institute NCI Cancer Center Support Grant. The Genetic Counseling Shared Resource facilitates basic science, clinical, and behavioral research that is necessary to translate genetic discoveries into clinical care.

Ms. Kohlmann's research interests focus on increasing access to genetic counseling and testing among diverse populations. She is currently a co-investigator on NCI and NIH funded grants focused on automated tools, such as algorithms and chatbots, to identify patients eligible for genetic testing using information in the electronic health record and to deliver pre and post-test genetic counseling. Ms. Kohlmann is leading a genetic counseling focused project with a national SPORE grant focused on leiomyosarcoma. This project will evaluate the interest in genetic testing among this patient population, and the psychosocial, behavioral, and family communication outcomes of receiving genetic information. The use of genetic testing is also increasing in pediatric populations. She is co-investigator on several studies focused on pediatric and young adults with cancer and hereditary cancer predisposition.

She sees patients clinically for genetic counseling and testing. She also coordinates the Li-Fraumeni Syndrome and Rare Tumors Clinic at Huntsman Cancer Institute.

Specialties

Wendy Kohlmann is a board certified genetic counselor with a master's degree from the University of Cincinnati. She joined the University of Utah Huntsman Cancer Institute in 2006. She is the Director of the Genetic Counseling Shared Resource, a core resource supported by the Huntsman Cancer Institute NCI Cancer Center Support Grant. The Genetic Counseling Shared Resource facilitates basic science, clinical, and behavioral research that is necessary to translate genetic discoveries into clinical care.

Ms. Kohlmann's research interests focus on increasing access to genetic counseling and testing among diverse populations. She is currently a co-investigator on NCI and NIH funded grants focused on automated tools, such as algorithms and chatbots, to identify patients eligible for genetic testing using information in the electronic health record and to deliver pre and post-test genetic counseling. Ms. Kohlmann is leading a genetic counseling focused project with a national SPORE grant focused on leiomyosarcoma. This project will evaluate the interest in genetic testing among this patient population, and the psychosocial, behavioral, and family communication outcomes of receiving genetic information. The use of genetic testing is also increasing in pediatric populations. She is co-investigator on several studies focused on pediatric and young adults with cancer and hereditary cancer predisposition.

She sees patients clinically for genetic counseling and testing. She also coordinates the Li-Fraumeni Syndrome and Rare Tumors Clinic at Huntsman Cancer Institute.

Board Certification and Academic Information

Academic Departments Population Health Sciences -Adjunct Associate Professor
Huntsman Cancer Institute -Midlevel

Education history

Undergraduate University of Wisconsin B.S.
Graduate Training Genetic Counseling - University of Cincinatti M.S.

Selected Publications

Journal Article

  1. Lloyd IE, Kohlmann WK, Gligorich K, Hall A, Lyon E, Downs-Kelly E, Samowitz WS, Bronner M (2017). A Clinicopathologic Evaluation of Incidental Fundic Gland Polyps With Dysplasia: Implications for Clinical Management. The American journal of gastroenterology, 112(7), 1094-1102.
  2. Albright FS, Kohlmann W, Neumayer L, Buys SS, Matsen CB, Kaphingst KA, Cannon-Albright L (2019). Population-based relative risks for specific family history constellations of breast cancer. Cancer causes & control, 30(6), 581-590.
  3. Wu YP, Kohlmann W, Curtin K, Yu Z, Hanson HA, Hashibe M, Parsons BG, Wong J, Schiffman JD, Grossman D, Leachman S (2018). Melanoma risk assessment based on relatives' age at diagnosis. Cancer causes & control, 29(2), 193-199.
  4. Kohlmann W, Schiffman J (2016). Discussing and managing hematologic germ line variants. Blood, 128(21), 2497-2503.
  5. Carmichael H, Matsen C, Freer P, Kohlmann W, Stein M, Buys SS, Colonna (2017). Breast cancer screening of pregnant and breastfeeding women with BRCA mutations. Breast cancer research and treatment, 162(2), 225-230.
  6. Wu YP, Aspinwall LG, Nagelhout E, Kohlmann W, Kaphingst KA, Homburger S, Perkins RD, Grossman D, Harding G, Cassidy P, Leachman S (2018). Development of an Educational Program Integrating Concepts of Genetic Risk and Preventive Strategies for Children with a Family History of Melanoma. Journal of cancer education, 33(4), 774-781.
  7. Li C, Liu T, Tavtigian SV, Boucher K, Kohlmann W, Cannon-Albright L, Grossman (2020). Targeted germline sequencing of patients with three or more primary melanomas reveals high rate of pathogenic variants. Melanoma research, 30(3), 247-251.
  8. Steffen LE, Du R, Gammon A, Mandelblatt JS, Kohlmann WK, Lee JH, Buys SS, Stroup AM, Campo RA, Flores KG, Vicuña B, Schwartz MD, Kinney A (2017). Genetic Testing in a Population-Based Sample of Breast and Ovarian Cancer Survivors from the REACH Randomized Trial: Cost Barriers and Moderators of Counseling Mode. Cancer epidemiology, biomarkers & prevention, 26(12), 1772-1780.
  9. Wu YP, Parsons BG, Mooney R, Aspinwall LG, Cloyes K, Hay JL, Kohlmann W, Grossman D, Leachman S (2018). Barriers and Facilitators to Melanoma Prevention and Control Behaviors Among At-Risk Children. Journal of community health, 43(5), 993-1001.
  10. Martin C, Leiser CL, O'Neil B, Gupta S, Lowrance WT, Kohlmann W, Greenberg S, Pathak P, Smith KR, Hanson H (2018). Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case-Control Study. Journal of the National Cancer Institute, 110(5), 527-533.
  11. Kinney AY, Steffen LE, Brumbach BH, Kohlmann W, Du R, Lee JH, Gammon A, Butler K, Buys SS, Stroup AM, Campo RA, Flores KG, Mandelblatt JS, Schwartz M (2016). Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up. Journal of clinical oncology, 34(24), 2914-24.
  12. Petersen J, Koptiuch C, Wu YP, Mooney R, Elrick A, Szczotka K, Keener M, Pappas L, Kanth P, Soisson A, Kohlmann W, Kaphingst K (2018). Patterns of family communication and preferred resources for sharing information among families with a Lynch syndrome diagnosis. Patient education and counseling, 101(11), 2011-2017.
  13. Wu YP, Nagelhout E, Aspinwall LG, Boucher KM, Parsons BG, Kohlmann W, Kaphingst KA, Homburger S, Perkins RD, Grossman D, Harding G, Leachman S (2018). A novel educational intervention targeting melanoma risk and prevention knowledge among children with a familial risk for melanoma. Patient education and counseling, 101(3), 452-459.
  14. Caliskan A, Kohlmann WK, Affolter KE, Downs-Kelly E, Kanth P, Bronner M (2018). Intramucosal lipomas of the colon implicate Cowden syndrome. Modern pathology, 31(4), 643-651.
  15. Wasserman JD, Tomlinson GE, Druker H, Kamihara J, Kohlmann WK, Kratz CP, Nathanson KL, Pajtler KW, Parareda A, Rednam SP, States LJ, Villani A, Walsh MF, Zelley K, Schiffman J (2017). Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clinical cancer research, 23(13), e123-e132.
  16. Druker H, Zelley K, McGee RB, Scollon SR, Kohlmann WK, Schneider KA, Wolfe Schneider (2017). Genetic Counselor Recommendations for Cancer Predisposition Evaluation and Surveillance in the Pediatric Oncology Patient. Clinical cancer research, 23(13), e91-e97.
  17. Rednam SP, Erez A, Druker H, Janeway KA, Kamihara J, Kohlmann WK, Nathanson KL, States LJ, Tomlinson GE, Villani A, Voss SD, Schiffman JD, Wasserman J (2017). Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clinical cancer research, 23(12), e68-e75.
  18. Kratz CP, Achatz MI, Brugières L, Frebourg T, Garber JE, Greer MC, Hansford JR, Janeway KA, Kohlmann WK, McGee R, Mullighan CG, Onel K, Pajtler KW, Pfister SM, Savage SA, Schiffman JD, Schneider KA, Strong LC, Evans DGR, Wasserman JD, Villani A, Malkin (2017). Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clinical cancer research, 23(11), e38-e45.
  19. Walsh MF, Chang VY, Kohlmann WK, Scott HS, Cunniff C, Bourdeaut F, Molenaar JJ, Porter CC, Sandlund JT, Plon SE, Wang LL, Savage S (2017). Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders. Clinical cancer research, 23(11), e23-e31.
  20. Wu YP, Boucher K, Hu N, Hay J, Kohlmann W, Aspinwall LG, Bowen DJ, Parsons BG, Nagelhout ES, Grossman D, Mooney K, Leachman SA, Tercyak K (2020). A pilot study of a telehealth family-focused melanoma preventive intervention for children with a family history of melanoma. Psycho-oncology, 29(1), 148-155.
  21. Taber JM, Aspinwall LG, Drummond DM, Stump TK, Kohlmann W, Champine M, Cassidy P, Leachman S (2021). Priority of Risk (But Not Perceived Magnitude of Risk) Predicts Improved Sun-Protection Behavior Following Genetic Counseling for Familial Melanoma. Annals of behavioral medicine, 55(1), 24-40.
  22. Young EL, Thompson BA, Neklason DW, Firpo MA, Werner T, Bell R, Berger J, Fraser A, Gammon A, Koptiuch C, Kohlmann WK, Neumayer L, Goldgar DE, Mulvihill SJ, Cannon-Albright LA, Tavtigian S (2018). Pancreatic cancer as a sentinel for hereditary cancer predisposition. BMC cancer, 18(1), 697.
  23. Hummel S, Kohlmann W, Kollmeyer TM, Jenkins R, Sonnen J, Palmer CA, Colman H, Abbott D, Cannon-Albright L, Cohen A (2019). The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database. BMC cancer, 19(1), 190.
  24. Stump TK, Aspinwall LG, Drummond DM, Taber JM, Kohlmann W, Champine M, Cassidy PB, Petrie T, Liley B, Leachman S (2020). CDKN2A testing and genetic counseling promote reductions in objectively measured sun exposure one year later. Genetics in medicine, 22(1), 26-34.
  25. Greenberg SE, Jacobs MF, Wachtel H, Anson A, Buchmann L, Cohen DL, Bonanni M, Bennett B, Naumer A, Schaefer AM, Kohlmann W, Nathanson KL, Else T, Fishbein (2020). Tumor detection rates in screening of individuals with SDHx-related hereditary paraganglioma-pheochromocytoma syndrome. Genetics in medicine, 22(12), 2101-2107.
  26. Stump TK, Aspinwall LG, Kohlmann W, Champine M, Hauglid J, Wu YP, Scott E, Cassidy P, Leachman S (2018). Genetic Test Reporting and Counseling for Melanoma Risk in Minors May Improve Sun Protection Without Inducing Distress. Journal of genetic counseling, 27(4), 955-967.
  27. Wu YP, Mays D, Kohlmann W, Tercyak K (2017). Pediatric Predispositional Genetic Risk Communication: Potential Utility for Prevention and Control of Melanoma Risk as an Exemplar. Journal of genetic counseling, 26(5), 887-893.
  28. Flores KG, Steffen LE, McLouth CJ, Vicuña BE, Gammon A, Kohlmann W, Vigil L, Dayao ZR, Royce ME, Kinney A (2017). Factors Associated with Interest in Gene-Panel Testing and Risk Communication Preferences in Women from BRCA1/2 Negative Families. Journal of genetic counseling, 26(3), 480-490.
  29. Kohlmann W, Schiffman J (2016). Discussing and managing hematologic germ line variants. Hematology. American Society of Hematology. Education Program, 2016(1), 309-315.
  30. Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H, Gallinger B, Naumer A, Kohlmann W, Novokmet A, Tabori U, Tijerin M, Greer ML, Finlay JL, Schiffman JD, Malkin (2016). Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. The Lancet. Oncology, 17(9), 1295-305.
  31. Johns D, Agarwal J, Anderson L, Ying J, Kohlmann (2017). Breast Cancer Risk Reduction Decisions of the BRCA-Positive Patient: An Observational Study at a Single Institution. Journal of women's health (2002), 26(6), 702-706.
  32. Gupta S, Greenberg S, Grimmett J, Gaston D, Agarwal N, Lowrance W, Schiffman J, Kohlmann (2017). Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers. Familial cancer, 16(4), 545-550.
  33. Tak CR, Biltaji E, Kohlmann W, Maese L, Hainaut P, Villani A, Malkin D, Sherwin CMT, Brixner DI, Schiffman J (2019). Cost-effectiveness of early cancer surveillance for patients with Li-Fraumeni syndrome. Pediatric blood & cancer, 66(5), e27629.
  34. Rengifo-Cam W, Shepherd HM, Jasperson KW, Samadder NJ, Samowitz W, Tripp SR, Schiffman JD, Kohlmann (2018). Colon Pathology Characteristics in Li-Fraumeni Syndrome. Clinical gastroenterology and hepatology, 16(1), 140-141.
  35. Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML, CGC., Karlan BY, Khan S, Klein C, Kohlmann W, CGC., Kurian AW, Laronga C, Litton JK, Mak JS, LCGC., Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G, CGC., Senter-Jamieson L, CGC., Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer M (2021). Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 19(1), 77-102.
  36. Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pal T, Pederson HJ, Reiser G, Shannon KM, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Dwyer MA, Darlow S (2020). NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. Journal of the National Comprehensive Cancer Network, 18(4), 380-391.
  37. Daly MB, Pilarski R, Berry M, Buys SS, Farmer M, Friedman S, Garber JE, Kauff ND, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Merajver SD, Offit K, Pal T, Reiser G, Shannon KM, Swisher E, Vinayak S, Voian NC, Weitzel JN, Wick MJ, Wiesner GL, Dwyer M, Darlow (2017). NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. Journal of the National Comprehensive Cancer Network, 15(1), 9-20.
  38. Reblin M, Birmingham WC, Kohlmann W, Graff (2018). Support and negation of colorectal cancer risk prevention behaviors: analysis of spousal discussions. Psychology, health & medicine, 23(5), 548-554.
  39. Mowery DL, Kawamoto K, Bradshaw R, Kohlmann W, Schiffman JD, Weir C, Borbolla D, Chapman WW, Del Fiol (2019). Determining Onset for Familial Breast and Colorectal Cancer from Family History Comments in the Electronic Health Record. AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science, 2019, 173-181.
  40. Wu YP, Aspinwall LG, Parsons B, Stump TK, Nottingham K, Kohlmann W, Champine M, Cassidy P, Leachman S (2020). Parent and child perspectives on family interactions related to melanoma risk and prevention after CDKN2A/p16 testing of minor children. Journal of community genetics, 11(3), 321-329.
  41. Aspinwall LG, Stump TK, Taber JM, Drummond DM, Kohlmann W, Champine M, Leachman S (2018). Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk. Translational behavioral medicine, 8(1), 29-43.
  42. Greenberg S, Buys SS, Edwards SL, Espinel W, Fraser A, Gammon A, Hafen B, Herget KA, Kohlmann W, Roundy C, Sweeney (2019). Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing. Cancer medicine, 8(15), 6789-6798.
  43. Hendrickson PG, Luo Y, Kohlmann W, Schiffman J, Maese L, Bishop AJ, Lloyd S, Kokeny KE, Hitchcock YJ, Poppe MM, Gaffney DK, Tao (2020). Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study. Cancer medicine, 9(21), 7954-7963.
  44. McCrary HC, Babajanian E, Calquin M, Carpenter P, Casazza G, Naumer A, Greenberg S, Kohlmann W, Cannon R, Monroe MM, Hunt JP, Buchmann (2019). Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades. JAMA otolaryngology-- head & neck surgery, 145(7), 641-646.
  45. Cannon-Albright LA, Teerlink CC, Stevens J, Snow AK, Thompson BA, Bell R, Nguyen KN, Sargent NR, Kohlmann WK, Neklason DW, Tavtigian S (2020). FANCM c5791C>T stopgain mutation (rs144567652) is a familial colorectal cancer risk factor. Molecular genetics & genomic medicine, 8(12), e1532.
  46. Ballinger ML, Best A, Mai PL, Khincha PP, Loud JT, Peters JA, Achatz MI, Chojniak R, Balieiro da Costa A, Santiago KM, Garber J, O'Neill AF, Eeles RA, Evans DG, Bleiker E, Sonke GS, Ruijs M, Loo C, Schiffman J, Naumer A, Kohlmann W, Strong LC, Bojadzieva J, Malkin D, Rednam SP, Stoffel EM, Koeppe E, Weitzel JN, Slavin TP, Nehoray B, Robson M, Walsh M, Manelli L, Villani A, Thomas DM, Savage S (2017). Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis. JAMA oncology, 3(12), 1634-1639.
  47. Colonna S, Curtin K, Johnson E, Kohlmann W, Wright J, Kirchhoff A, Tavtigian S, Schiffman (2019). Family History of Breast Cancer Associated with Breast Cancer in Survivors of Hodgkin Lymphoma. International journal of cancer and clinical research, 6(1),
  48. Boyle JL, Hahn AW, Kapron AL, Kohlmann W, Greenberg SE, Parnell TJ, Teerlink CC, Maughan BL, Feng BJ, Cannon-Albright L, Agarwal N, Cooney K (2020). Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer. JCO precision oncology, 4,
  49. Del Fiol G, Kohlmann W, Bradshaw RL, Weir CR, Flynn M, Hess R, Schiffman JD, Nanjo C, Kawamoto (2020). Standards-Based Clinical Decision Support Platform to Manage Patients Who Meet Guideline-Based Criteria for Genetic Evaluation of Familial Cancer. JCO clinical cancer informatics, 4, 1-9.
  50. Zhong L, Bather JR, Daly BM, Kohlmann WK, Goodman MS, Rothwell E, Kaphingst K (2023). Investigation of interest in and timing preference for cancer predisposition testing and expanded carrier screening among women of reproductive age. PEC innovation, 2, 100128.
  51. Watkins MT, Kohlmann WK, Berry TS, Sama NR, Koptiuch C, Rynearson SG, Eilbeck K (2023). LocalVar: a local variant collection manager to asynchronously detect synonyms, HGVS expression changes, and variant interpretation changes from ClinVar. AMIA ... Annual Symposium proceedings. AMIA Symposium, 2022, 1145-1152.
  52. Chavez-Yenter D, Goodman MS, Chen Y, Chu X, Bradshaw RL, Lorenz Chambers R, Chan PA, Daly BM, Flynn M, Gammon A, Hess R, Kessler C, Kohlmann WK, Mann DM, Monahan R, Peel S, Kawamoto K, Del Fiol G, Sigireddi M, Buys SS, Ginsburg O, Kaphingst K (2022). Association of Disparities in Family History and Family Cancer History in the Electronic Health Record With Sex, Race, Hispanic or Latino Ethnicity, and Language Preference in 2 Large US Health Care Systems. JAMA network open, 5(10), e2234574.
  53. Aspinwall LG, Drummond DM, Stump TK, Kohlmann WK, Leachman S (2022). Interactive Beliefs about Genes and Behavior Predict Improved Sun Protection Following Melanoma Genetic Counseling. Annals of behavioral medicine, 56(8), 816-829.
  54. Kaphingst KA, Bather JR, Daly BM, Chavez-Yenter D, Vega A, Kohlmann W (2022). Interest in Cancer Predisposition Testing and Carrier Screening Offered as Part of Routine Healthcare Among an Ethnically Diverse Sample of Young Women. Frontiers in genetics, 13, 866062.
  55. Bradshaw RL, Kawamoto K, Kaphingst KA, Kohlmann WK, Hess R, Flynn MC, Nanjo CJ, Warner PB, Shi J, Morgan K, Kimball K, Ranade-Kharkar P, Ginsburg O, Goodman M, Chambers R, Mann D, Narus SP, Gonzalez J, Loomis S, Chan P, Monahan R, Borsato EP, Shields DE, Martin DK, Kessler CM, Del Fiol (2022). GARDE: a standards-based clinical decision support platform for identifying population health management cohorts. Journal of the American Medical Informatics Association, 29(5), 928-936.
  56. Kanth P, Yu Z, Keener MB, Koptiuch C, Kohlmann WK, Neklason DW, Westover M, Curtin (2022). Cancer Risk in Patients With and Relatives of Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesions. The American journal of gastroenterology, 117(2), 336-342.
  57. Kawamoto K, Kukhareva PV, Weir C, Flynn MC, Nanjo CJ, Martin DK, Warner PB, Shields DE, Rodriguez-Loya S, Bradshaw RL, Cornia RC, Reese TJ, Kramer HS, Taft T, Curran RL, Morgan KL, Borbolla D, Hightower M, Turnbull WJ, Strong MB, Chapman WW, Gregory T, Stipelman CH, Shakib JH, Hess R, Boltax JP, Habboushe JP, Sakaguchi F, Turner KM, Narus SP, Tarumi S, Takeuchi W, Ban H, Wetter DW, Lam C, Caverly TJ, Fagerlin A, Norlin C, Malone DC, Kaphingst KA, Kohlmann WK, Brooke BS, Del Fiol (2021). Establishing a multidisciplinary initiative for interoperable electronic health record innovations at an academic medical center. JAMIA open, 4(3), ooab041.
  58. Koptiuch C, Espinel WF, Kohlmann WK, Zhao J, Kaphingst K (2021). Implications of Multigene Panel Testing on Psychosocial Outcomes: A Comparison of Patients With Pancreatic and Breast or Ovarian Cancer. JCO precision oncology, 5,
  59. Wu YP, Hamilton JG, Kaphingst KA, Jensen JD, Kohlmann W, Parsons BG, Lillie HM, Wang X, Haaland B, Wankier AP, Grossman D, Hay J (2023). Increasing Skin Cancer Prevention in Young Adults: the Cumulative Impact of Personalized UV Photography and MC1R Genetic Testing. Journal of cancer education, 38(3), 1059-1065.
  60. Subasri V, Light N, Kanwar N, Brzezinski J, Luo P, Hansford JR, Cairney E, Portwine C, Elser C, Finlay JL, Nichols KE, Alon N, Brunga L, Anson J, Kohlmann W, de Andrade KC, Khincha PP, Savage SA, Schiffman JD, Weksberg R, Pugh TJ, Villani A, Shlien A, Goldenberg A, Malkin (2023). Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni Syndrome. Cancer research communications, 3(5), 738-754.
  61. Foley M, Sharma A, Garfield K, Maese L, Buchmann L, Boyle J, Kohlmann W, Jeter J, Greenberg (2023). A need to tailor surveillance based on family history: describing a highly penetrant familial paraganglioma kindred with an SDHD pathogenic variant. Familial cancer, 22(2), 217-224.
  62. Liebermann E, Taber P, Vega AS, Daly BM, Goodman MS, Bradshaw R, Chan PA, Chavez-Yenter D, Hess R, Kessler C, Kohlmann W, Low S, Monahan R, Kawamoto K, Del Fiol G, Buys SS, Sigireddi M, Ginsburg O, Kaphingst K (2022). Barriers to family history collection among Spanish-speaking primary care patients: a BRIDGE qualitative study. PEC innovation, 1,
  63. Brady HL, Hamilton JG, Kaphingst KA, Jensen JD, Kohlmann W, Parsons BG, Lillie HM, Wankier AP, Smith HJ, Grossman D, Hay JL, Wu Y (2022). 'I had a bigger cancer risk than I thought¿': The experience of receiving personalized risk information as part of a skin cancer prevention intervention in the college setting. Health expectations, 25(6), 2937-2949.
  64. Shi J, Morgan KL, Bradshaw RL, Jung SH, Kohlmann W, Kaphingst KA, Kawamoto K, Fiol G (2022). Identifying Patients Who Meet Criteria for Genetic Testing of Hereditary Cancers Based on Structured and Unstructured Family Health History Data in the Electronic Health Record: Natural Language Processing Approach. JMIR medical informatics, 10(8), e37842.
  65. Mooney R, Espinel W, Elrick A, Kehoe K, Kohlmann W, Kaphingst K (2022). Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing. Journal of genetic counseling, 31(2), 470-478.
  66. Taber P, Ghani P, Schiffman JD, Kohlmann W, Hess R, Chidambaram V, Kawamoto K, Waller RG, Borbolla D, Del Fiol G, Weir (2020). Physicians' strategies for using family history data: having the data is not the same as using the data. JAMIA open, 3(3), 378-385.
  67. Kerrigan K, Chan J, Vagher J, Kohlmann W, Naumer A, Anson J, Low S, Schiffman J, Maese (2021). Lung Cancer in Li-Fraumeni Syndrome. JCO precision oncology, 5,
  68. Greenberg SE, Holman R, Kohlmann W, Buchmann L, Naumer (2021). Paraganglioma and other tumour detection rates in individuals with SDHx pathogenic variants by age of diagnosis and after the age of 50. Clinical endocrinology, 95(3), 447-452.

Review

  1. Vagher J, Gammon A, Kohlmann W, Jeter (2022). Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders. Frontiers in oncology, 12, 837059.

Case Report

  1. Donovan LN, Kohlmann W, Snow AK, Neklason DW, Schiffman JD, Maese (2020). Germ Cell Mosaicism: A Rare Cause of Li-Fraumeni Recurrence Among Siblings. JCO precision oncology, 4,

Editorial

  1. Kohlmann (2020). Lynch Syndrome and Breast Cancer Risk: Weighing the Data. JCO precision oncology, 4,

Letter

  1. Thompson BA, Snow AK, Koptiuch C, Kohlmann WK, Mooney R, Johnson S, Huff CD, Yu Y, Teerlink CC, Feng BJ, Neklason DW, Cannon-Albright LA, Tavtigian S (2020). A novel ribosomal protein S20 variant in a family with unexplained colorectal cancer and polyposis. Clinical genetics, 97(6), 943-944.
  2. Kinney AY, Kohlmann W, Brumbach BH, Schwartz M (2017). Reply to P.R. Benusiglio et al. Journal of clinical oncology, 35(11), 1255-1256.

Other

  1. Shi J, Morgan KL, Bradshaw RL, Jung SH, Kohlmann W, Kaphingst KA, Kawamoto K, Fiol G (2022). Correction: Identifying Patients Who Meet Criteria for Genetic Testing of Hereditary Cancers Based on Structured and Unstructured Family Health History Data in the Electronic Health Record: Natural Language Processing Approach. JMIR medical informatics, 10(9), e42533.

News & Podcasts

Podcasts